The molecular markers of NA inhibitors (oseltamivir and zanamivir) [22] and ion-channel inhibitors (amantadine and rimantadine) [26, 28] in the NA and M2 proteins of the A/AI-1606/16 virus exhibited no mutations, suggesting susceptibility to these antiviral influenza drugs. Here, XK is linked to influenza.